Key Laboratory of Translational Medicine of Guangdong

Guangzhou, China

Key Laboratory of Translational Medicine of Guangdong

Guangzhou, China
SEARCH FILTERS
Time filter
Source Type

Chen T.,Center for Tuberculosis Control of Guangdong Province | Chen T.,Key Laboratory of Translational Medicine of Guangdong | Li Q.,Jinan University | Guo L.,Guangdong Provincial Hospital of Chinese Medicine | And 16 more authors.
Materials Science and Engineering C | Year: 2016

To overcome the undesirable side effects and reduce the cytotoxicity of isoniazid (INH) and rifampin (RMP) in the digestive tract, a poly(methacrylic acid) (PMAA) nanogel was developed as a carrier of INH and RMP. This PMAA/INH/RMP nanogel was prepared as a treatment for intestinal tuberculosis caused by multidrug-resistant Mycobacterium tuberculosis (MTB). The morphology, size, and in vitro release properties were evaluated in a simulated gastrointestinal medium, and long-term antibacterial performance, cytotoxicity, stability, and activity of this novel PMAA/INH/RMP nanogel against multidrug-resistant MTB in the intestine were investigated. Our results indicate that the PMAA/INH/RMP nanogel exhibited extended antibacterial activity by virtue of its long-term release of INH and RMP in the simulated gastrointestinal medium. Further, this PMAA/INH/RMP nanogel exhibited lower cytotoxicity than did INH or RMP alone, suggesting that this PMAA/INH/RMP nanogel could be a more useful dosage form than separate doses of INH and RMP for intestinal MTB. The novel aspects of this study include the cytotoxicity study and the three-phase release profile study, which might be useful for other researchers in this field. © 2015 Published by Elsevier B.V. All rights reserved.

Loading Key Laboratory of Translational Medicine of Guangdong collaborators
Loading Key Laboratory of Translational Medicine of Guangdong collaborators